A detailed history of Susquehanna International Group, LLP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 79,695 shares of LAB stock, worth $145,841. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,695
Previous 222,991 64.26%
Holding current value
$145,841
Previous $394,000 61.17%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.42 - $2.35 $203,480 - $336,745
-143,296 Reduced 64.26%
79,695 $153,000
Q2 2024

Aug 15, 2024

SELL
$1.65 - $2.92 $3.09 Million - $5.47 Million
-1,872,100 Reduced 89.36%
222,991 $394,000
Q1 2024

May 07, 2024

BUY
$1.87 - $2.78 $3.59 Million - $5.33 Million
1,917,845 Added 1082.02%
2,095,091 $5.68 Million
Q4 2023

Feb 14, 2024

BUY
$1.59 - $2.73 $128,813 - $221,170
81,015 Added 84.19%
177,246 $391,000
Q3 2023

Nov 14, 2023

BUY
$1.9 - $3.05 $47,538 - $76,311
25,020 Added 35.14%
96,231 $279,000
Q2 2023

Aug 11, 2023

SELL
$1.47 - $2.56 $126,706 - $220,659
-86,195 Reduced 54.76%
71,211 $137,000
Q1 2023

May 16, 2023

BUY
$1.3 - $2.24 $148,549 - $255,962
114,269 Added 264.9%
157,406 $306,000
Q4 2022

Feb 14, 2023

BUY
$0.93 - $1.52 $40,117 - $65,568
43,137 New
43,137 $50,000
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.99 $118,110 - $294,537
73,819 Added 76.46%
170,368 $273,000
Q1 2022

May 16, 2022

SELL
$2.8 - $3.96 $63,949 - $90,442
-22,839 Reduced 19.13%
96,549 $347,000
Q4 2021

Feb 14, 2022

SELL
$3.63 - $6.13 $56,148 - $94,818
-15,468 Reduced 11.47%
119,388 $468,000
Q3 2021

Nov 15, 2021

BUY
$5.5 - $7.41 $85,013 - $114,536
15,457 Added 12.95%
134,856 $889,000
Q2 2021

Aug 11, 2021

SELL
$4.35 - $6.35 $1.63 Million - $2.38 Million
-374,385 Reduced 75.82%
119,399 $735,000
Q1 2021

May 17, 2021

BUY
$3.94 - $7.09 $392,313 - $705,965
99,572 Added 25.26%
493,784 $2.23 Million
Q4 2020

Feb 16, 2021

BUY
$5.45 - $8.65 $1.91 Million - $3.03 Million
350,328 Added 798.3%
394,212 $2.37 Million
Q3 2020

Nov 16, 2020

BUY
$4.34 - $11.43 $34,733 - $91,474
8,003 Added 22.3%
43,884 $326,000
Q2 2020

Aug 14, 2020

BUY
$1.85 - $5.29 $10,049 - $28,735
5,432 Added 17.84%
35,881 $144,000
Q1 2020

May 15, 2020

SELL
$1.24 - $4.35 $6,979 - $24,486
-5,629 Reduced 15.6%
30,449 $77,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $5.12 $142,632 - $317,511
-62,014 Reduced 63.22%
36,078 $126,000
Q3 2019

Nov 14, 2019

BUY
$4.63 - $12.15 $261,891 - $687,252
56,564 Added 136.21%
98,092 $454,000
Q2 2019

Aug 16, 2019

BUY
$11.49 - $14.17 $358,074 - $441,593
31,164 Added 300.69%
41,528 $512,000
Q4 2018

Feb 14, 2019

SELL
$7.18 - $8.83 $183,764 - $225,995
-25,594 Reduced 71.18%
10,364 $89,000
Q2 2018

Aug 14, 2018

BUY
$4.86 - $6.24 $174,755 - $224,377
35,958 New
35,958 $214,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.